drugset / Trial / NCT03111615
HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer
RandomizedParallel-groupTriple-blindTreatment
Summary
Breast Cancer is a public health issue worldwide. The time from diagnosis to treatment initiation varies from country to country and regionally within a country. Early diagnosis and prompt treatment initiation are key factors in patient survival rates. Currently there is a rising trend, with a high percentage of patients with "Luminal" like breast cancer only undergoing adjuvant endocrine therapy. Authors argue that tumor biology alterations after introducing very early endocrine therapy might have a prognostic and therapeutic impact and should be studied.
Timeline
- Start
- 2018-05-01
- Primary completion
- 2019-05-01
- Completion
- 2020-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | — |
| Subject | Letrozole | Other / unclassified | 2.5 mg | — |